Abstract

Outer membrane proteins (OMPs) in Gram-negative bacteria are essential for a number of cellular functions including nutrient transport and drug efflux. Escherichia coli BamA is an essential component of the OMP β-barrel assembly machinery and a potential novel antibacterial target that has been proposed to undergo large (~15 Å) conformational changes. Here, we explored methods to isolate anti-BamA monoclonal antibodies (mAbs) that might alter the function of this OMP and ultimately lead to bacterial growth inhibition. We first optimized traditional immunization approaches but failed to identify mAbs that altered cell growth after screening >3000 hybridomas. We then developed a “targeted boost-and-sort” strategy that combines bacterial cell immunizations, purified BamA protein boosts, and single hybridoma cell sorting using amphipol-reconstituted BamA antigen. This unique workflow improves the discovery efficiency of FACS + mAbs by >600-fold and enabled the identification of rare anti-BamA mAbs with bacterial growth inhibitory activity in the presence of a truncated lipopolysaccharide layer. These mAbs represent novel tools for dissecting the BamA-mediated mechanism of β-barrel folding and our workflow establishes a new template for the efficient discovery of novel mAbs against other highly dynamic membrane proteins.

Details

Title
A targeted boost-and-sort immunization strategy using Escherichia coli BamA identifies rare growth inhibitory antibodies
Author
Vij, Rajesh 1 ; Lin, Zhonghua 1 ; Chiang, Nancy 1 ; Jean-Michel Vernes 2 ; Storek, Kelly M 3 ; Park, Summer 4 ; Chan, Joyce 2 ; Meng, Y Gloria 2 ; Comps-Agrar, Laetitia 2 ; Peng Luan 1 ; Lee, Sophia 1 ; Schneider, Kellen 1 ; Bevers, Jack, III 1 ; Zilberleyb, Inna 5 ; Tam, Christine 5 ; Koth, Christopher M 6 ; Xu, Min 4 ; Gill, Avinash 1 ; Auerbach, Marcy R 3 ; Smith, Peter A 3 ; Rutherford, Steven T 3 ; Nakamura, Gerald 1 ; Dhaya Seshasayee 1 ; Payandeh, Jian 6 ; Koerber, James T 1 

 Department of Antibody Engineering, Genentech, 1 DNA Way, South San Francisco, California, USA 
 Department of Biochemical and Cellular Pharmacology, Genentech, 1 DNA Way, South San Francisco, California, USA 
 Department of Infectious Diseases, Genentech, 1 DNA Way, South San Francisco, California, USA 
 Department of Translational Immunology, Genentech, 1 DNA Way, South San Francisco, California, USA 
 Department of BioMolecular Resources, Genentech, 1 DNA Way, South San Francisco, California, USA 
 Department of Structural Biology, Genentech, 1 DNA Way, South San Francisco, California, USA 
Pages
1-10
Publication year
2018
Publication date
May 2018
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2036393111
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.